312 related articles for article (PubMed ID: 36046913)
1. [Network Meta-analysis of six Chinese patent medicines for replenishing Qi and activating blood in treatment of chronic heart failure].
Park YS; Wang W; Li YD; Liu K
Zhongguo Zhong Yao Za Zhi; 2022 Aug; 47(15):4221-4237. PubMed ID: 36046913
[TBL] [Abstract][Full Text] [Related]
2. [Network Meta-analysis of Chinese patent medicines in treatment of coronary heart disease complicated with heart failure].
Wang AL; Wei JJ; Sun Y; Guo HX; Zhang MJ; Lu JF; Zhang YL; Peng GC; Zhu MJ
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(2):518-533. PubMed ID: 38403327
[TBL] [Abstract][Full Text] [Related]
3. [Network Meta-analysis of Chinese patent medicine in treatment of heart failure with preserved ejection fraction].
Tian J; Xu BR; Xing ZY; Qiu BY; Si CY; Zhu MJ; Wang YX
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(3):819-835. PubMed ID: 38621886
[TBL] [Abstract][Full Text] [Related]
4. [Network Meta-analysis of 11 Chinese patent medicines in treatment of dilated cardiomyopathy].
Wang ZX; Wang H; Ban JF; Zhou YB; Qie R
Zhongguo Zhong Yao Za Zhi; 2023 Dec; 48(24):6778-6797. PubMed ID: 38212037
[TBL] [Abstract][Full Text] [Related]
5. [Network Meta-analysis of Yiqi Huoxue Chinese patent medicine for coronary heart disease with angina pectoris].
Ji ZC; Hu HY; Yang FW; Zhang LS; Jin XY; Wang HC; Pang WT; Li N; Wang KY; Zhang JH
Zhongguo Zhong Yao Za Zhi; 2019 May; 44(9):1927-1937. PubMed ID: 31342723
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Oral Chinese Patent Medicine Combined with Conventional Therapy for Heart Failure: An Overview of Systematic Reviews.
Lin SS; Liu CX; Zhang JH; Wang XL; Mao JY
Evid Based Complement Alternat Med; 2020; 2020():8620186. PubMed ID: 32908572
[TBL] [Abstract][Full Text] [Related]
7. [Network Meta-analysis of oral blood-activating and stasis-removing Chinese patent medicines in treatment of hypertensive left ventricular hypertrophy].
Zheng YW; Li J; Yao WQ; Pan MY; Fang Y
Zhongguo Zhong Yao Za Zhi; 2022 Mar; 47(5):1383-1391. PubMed ID: 35343167
[TBL] [Abstract][Full Text] [Related]
8. [Network Meta-analysis of Qi-benefiting and blood-activating Chinese patent medicines against ischemic stroke].
Zhu LJ; DU HR; Li HL; Wang Y; Yang Z
Zhongguo Zhong Yao Za Zhi; 2023 Jun; 48(11):3097-3109. PubMed ID: 37381968
[TBL] [Abstract][Full Text] [Related]
9. [Network Meta-analysis of Chinese patent medicine in treatment of unstable angina pectoris].
Zhang LM; DU TH; Niu LL; Wang LY; Li JN; Ma PF; Yu R
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(3):703-711. PubMed ID: 33645038
[TBL] [Abstract][Full Text] [Related]
10. [Network Meta-analysis of Qi-supplementing and Yin-nourishing Chinese patent medicines in treatment of early diabetic nephropathy].
Wang WR; Zhang XM; Li JX; Yang JY; Yu RH; Xie YM
Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(14):3949-3964. PubMed ID: 37475086
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Chinese traditional patent medicines for heart failure with preserved ejection fraction: a Bayesian network meta-analysis of 64 randomized controlled trials.
Guo H; Zhu M; Yu R; Li X; Zhao Q
Front Cardiovasc Med; 2023; 10():1255940. PubMed ID: 38054101
[TBL] [Abstract][Full Text] [Related]
12. [Network Meta-analysis of different Chinese medicine injections combined with conventional western medicine in treatment of acute heart failure].
Wang W; Kong FT; Li R; Zhao XK; Li YD; Liu K
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):251-267. PubMed ID: 38403358
[TBL] [Abstract][Full Text] [Related]
13. [Network Meta-analysis of oral Chinese patent medicines in treating type 2 diabetes mellitus complicated with angina pectoris of coronary heart disease].
Zhang XM; Zhao XX; Liu Y; Xie YM
Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(18):5078-5090. PubMed ID: 37802850
[TBL] [Abstract][Full Text] [Related]
14. [Network Meta-analysis of efficacy and safety of oral Chinese patent medicines combined with conventional western medicine in treatment of hypertension].
Ji ZC; Lin SS; Hu HY; Sheng XD; Yang FW; Wang XL
Zhongguo Zhong Yao Za Zhi; 2022 Apr; 47(7):1955-1988. PubMed ID: 35534266
[TBL] [Abstract][Full Text] [Related]
15. [Network Meta-analysis of Chinese patent medicine containing Hirudo in treatment of atherosclerosis].
Han QQ; Wen ZY; Lyu Q; Pan YY
Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(1):234-246. PubMed ID: 36725276
[TBL] [Abstract][Full Text] [Related]
16. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure.
Li X; Zhang J; Huang J; Ma A; Yang J; Li W; Wu Z; Yao C; Zhang Y; Yao W; Zhang B; Gao R;
J Am Coll Cardiol; 2013 Sep; 62(12):1065-1072. PubMed ID: 23747768
[TBL] [Abstract][Full Text] [Related]
17. [Comparative analysis of clinical effects according to syndrome differentiation of Qili Qiangxin Capsules on ischemic heart failure: Meta-analysis].
Sun YL; Ruan XF; Li YP; Wang XL
Zhongguo Zhong Yao Za Zhi; 2019 Nov; 44(22):4975-4984. PubMed ID: 31872608
[TBL] [Abstract][Full Text] [Related]
18. [Network Meta-analysis of efficacy of seven Chinese patent medicines in treatment of inflammatory response in chronic glomerulonephritis].
Shi RY; Zhang KX; Zhou XJ; Yang K; Wang XX; Zhang LQ
Zhongguo Zhong Yao Za Zhi; 2023 Nov; 48(22):6200-6215. PubMed ID: 38114227
[TBL] [Abstract][Full Text] [Related]
19. [Network Meta-analysis of efficacy of Chinese patent medicine in treatment of inflammatory response in diabetic nephropathy].
Shi RY; Zhang LQ; Zhang KX; Li QR; Wang XX; Yang K
Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3633-3649. PubMed ID: 37474996
[TBL] [Abstract][Full Text] [Related]
20. [Network Meta-analysis of oral or nasal feeding with Chinese patent medicine in treatment of hypertensive intracerebral hemorrhage].
Lei L; Jia M; Liao X; Lu Y; Zhang YL; Liang X; Chen Q; Fu GJ
Zhongguo Zhong Yao Za Zhi; 2021 Jun; 46(12):2995-3006. PubMed ID: 34467689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
